Navigation Links
New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Date:2/20/2013

ction to PRADAXA (e.g., anaphylactic reaction or anaphylactic shock)
  • A mechanical prosthetic heart valve 
  • WARNINGS & PRECAUTIONS 
    Risk of Bleeding

    PRADAXA increases the risk of bleeding and can cause significant and, sometimes, fatal bleeding. Promptly evaluate any signs or symptoms of blood loss (e.g., a drop in hemoglobin and/or hematocrit or hypotension). Discontinue PRADAXA in patients with active pathological bleeding.

    Risk factors for bleeding include concomitant use of medications that increase the risk of bleeding (e.g., anti-platelet agents, heparin, fibrinolytic therapy, and chronic use of NSAIDs). PRADAXA's anticoagulant activity and half-life are increased in patients with renal impairment. 

    A specific reversal agent for dabigatran is not available. Hemodialysis can remove dabigatran; however clinical experience for hemodialysis as a treatment for bleeding is limited. Activated prothrombin complex concentrates, recombinant Factor VIIa, or concentrates of factors II, IX or X may be considered but their use has not been evaluated. Protamine sulfate and vitamin K are not expected to affect dabigatran anticoagulant activity. Consider administration of platelet concentrates where thrombocytopenia is present or long-acting antiplatelet drugs have been used. 

    Thromboembolic and Bleeding Events in Patients with Prosthetic Heart Valves
    The safety and efficacy of PRADAXA in patients with bileaflet mechanical prosthetic heart valves (recently implanted or implanted more than 3 months prior to enrollment) was evaluated in the phase 2 RE-ALIGN trial. RE-ALIGN was terminated early because of significantly more thromboembolic events (valve thrombosis, stroke, transient ischemic attack, and myocardial infarction) and an excess of major bleeding (predominantly post-operative pericardial effusions requiring intervention for hemodynamic compromise) for PRADAXA vs warfarin. Therefore, the use
    '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
    3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
    4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
    5. Shingles Vaccine is Safe, According to New Study
    6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
    7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
    9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
    10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
    11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... Md. , Nov. 26, 2014  Over 100 ... of those suffer from this pain daily. Chronic and ... of pain management is born to fulfill the need ... all types of pain. On October 28th, ... the Cumberland, Maryland community.  This ...
    (Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
    (Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
    Breaking Medicine Technology:New Pain Management Center Opens in Cumberland, Md. 2Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4
    ... PLAINSBORO, N.J., Aug. 1, 2011 Diabetes company ... by Ivy Equities and LCOR in partnership with ... million redevelopment project to completely renovate and upgrade ... Center in Plainsboro, N.J., that will serve as ...
    ... Mass., Aug. 1, 2011 Hologic, Inc. (Hologic or the ... and supplier of premium diagnostics products, medical imaging systems and ... today announced its results for the third fiscal quarter ended ... quarter include: Revenues of $451.1 million resulting from year-over-year ...
    Cached Medicine Technology:Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 2Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 3Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 4Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Company's New U.S. Headquarters 5Hologic Announces Third Quarter Fiscal 2011 Operating Results 2Hologic Announces Third Quarter Fiscal 2011 Operating Results 3Hologic Announces Third Quarter Fiscal 2011 Operating Results 4Hologic Announces Third Quarter Fiscal 2011 Operating Results 5Hologic Announces Third Quarter Fiscal 2011 Operating Results 6Hologic Announces Third Quarter Fiscal 2011 Operating Results 7Hologic Announces Third Quarter Fiscal 2011 Operating Results 8Hologic Announces Third Quarter Fiscal 2011 Operating Results 9Hologic Announces Third Quarter Fiscal 2011 Operating Results 10Hologic Announces Third Quarter Fiscal 2011 Operating Results 11Hologic Announces Third Quarter Fiscal 2011 Operating Results 12Hologic Announces Third Quarter Fiscal 2011 Operating Results 13Hologic Announces Third Quarter Fiscal 2011 Operating Results 14Hologic Announces Third Quarter Fiscal 2011 Operating Results 15Hologic Announces Third Quarter Fiscal 2011 Operating Results 16Hologic Announces Third Quarter Fiscal 2011 Operating Results 17Hologic Announces Third Quarter Fiscal 2011 Operating Results 18Hologic Announces Third Quarter Fiscal 2011 Operating Results 19Hologic Announces Third Quarter Fiscal 2011 Operating Results 20
    (Date:11/28/2014)... 28, 2014 Dr. Andrew Campbell, one ... announced the expansion of Quintessa Aesthetic Center into a ... located at W307 N1497 Golf Road in Suite 200 ... Dr. Campbell, the new Delafield location will offer a ... patients, including: Botox, filler injectables , micro laser ...
    (Date:11/28/2014)... 2014 The Alternative Health ... the past five years. The industry has been ... that are either alternative to conventional Western medicine ... industry analyst David Whytcross, “industry revenue has been ... private health insurance membership.” Meanwhile, improving economic conditions ...
    (Date:11/28/2014)... News) -- Planning on seconds at Thanksgiving Day dinner ... known as gastroesophageal reflux disease (GERD) -- a few steps ... ear, nose and throat specialist at Lenox Hill Hospital in ... GERD on Thanksgiving: Pace yourself. Rather ... meals throughout the day. It,s also a good idea to ...
    (Date:11/28/2014)... 28, 2014 An inventor and dental assistant ... a patient’s filling and it was almost impossible to reach. ... light," she said. , The patent-pending Access Light allows for ... to areas of the mouth, as well as avoids harm ... safety. Easy to use and clean, it also helps prevent ...
    (Date:11/28/2014)... 2014 A newly released article ... of the influenza virus that will soon be spreading across ... The article begins with a brief explanation of what the ... reminds families that children under the age of 5, adults ... diseases, such as heart and lung diseases, asthma, or diabetes, ...
    Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
    ... increase in Social Security Disability Insurance recipients; time-intensive process of receiving ... Allsup , ... Belleville, Ill. (Vocus) June 25, 2008 ... Insurance (SSDI) benefits continued to grow in 2007. This means ...
    ... The National Intelligence Council (NIC) has completed a new ... U.S. security in the next 20 years by causing ... over water and other resources in specific countries. The ... June 25, on the main findings. , ...
    ... are the workhorses of our cells. They help to digest ... and literally shape our body from top to toe. Proteins ... of enzymes, which are important in the creation of anything ... possibilities are virtually without limit. , To take advantage ...
    ... of venous thromboembolism, study finds , , WEDNESDAY, June 25 ... rivaroxaban helps prevent potentially fatal blood clots after hip ... of venous thromboembolism (VTE) is high after total hip ... leaves hospital. Current guidelines recommend patients receive a heparin-based ...
    ... Pharmavite, a leader in the,dietary ... consumer-centric,program, LearnSomethingAbout(TM), as a partner in ... consumer-oriented multimedia,program that seamlessly integrates into ... "LearnSomething shares similar goals with Pharmavite ...
    ... MedeFile,International, Inc. (OTC Bulletin Board: MDFI), a company ... announced,that a highly exclusive, membership only, resort community ... memberships and is offering,MedeFile,s full suite of products ... 1,400 members., Members who subscribe to MedeFile,s ...
    Cached Medicine News:Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Climate change may challenge national security, classified report warns 2Health News:Climate change may challenge national security, classified report warns 3Health News:1 step closer to green chemistry and improved pharmaceuticals 2Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere 2
    Arthroscopic instrument system for instability and SLAP fixation....
    Suture Cutter, Open Ended, Left Notch...
    Suture Cutters, Straight...
    Portal accessory instrument set. Set also includes a package of 8 mm Guide Wires (.15 cm x 38 cm), and Sterilization Tray....
    Medicine Products: